Literature DB >> 958506

Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis.

N Heni, P Glogner.   

Abstract

A gas chromatographic method for the determination of phenprocoumon (Marcumar) in serum and urine is described, which facilitates accurate values down to 0.5 mug phenprocoumon/ml serum. After the i.v. administration of 20 mg phenprocoumon in a single dose to 4 healthy volunteers the following pharmacokinetic data were obtained: After the initial fast decrease (phase 1) of the serum level of phenprocoumon, probably due to the distribution into the different compartments is followed by a subsequent slower fall (phase 2) which occurs with a serum half-life of 157 h. The apparent distribution volume was 6.51. Analysis of the urine demonstrated that 90% of the excreted phenprocoumon detected was in the glucuronide form.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 958506     DOI: 10.1007/BF00499225

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  6 in total

1.  [Pharmacokinetica and metabolism of phenprocoumon--"marcumar" in man].

Authors:  P Glogner; N Heni
Journal:  Verh Dtsch Ges Inn Med       Date:  1973

2.  Mass spectral analysis in the identification of human metabolites of warfarin.

Authors:  W F Trager; R J Lewis; W A Garland
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

3.  Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid.

Authors:  B Hüthwohl; E Jähnchen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Warfarin metabolism in man: identification of metabolites in urine.

Authors:  R J Lewis; W F Trager
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

5.  Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (marcoumar) in the plasma when tested in normal cases and under the influence of drugs.

Authors:  K Seiler; F Duckert
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

6.  [Binding of phenprocoumarol (Marcumar) to human albumin].

Authors:  R Niedner; U von Oettingen; F Meyer
Journal:  Int J Clin Pharmacol       Date:  1973-10
  6 in total
  9 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Treatment of phenprocoumon intoxication with cholestyramine.

Authors:  T Meinertz; M J Gilfrich; R Bork; E Jahnchen
Journal:  Br Med J       Date:  1977-08-13

3.  The effect of wheat bran on the pharmacokinetics of phenprocoumon in normal volunteers.

Authors:  N R Kitteringham; S Mineshita; E E Ohnhaus
Journal:  Klin Wochenschr       Date:  1985-06-18

4.  Factors responsible for interindividual differences in the dose requirement of phenprocoumon.

Authors:  D Trenk; H Althen; E Jähnchen; T Meinertz; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Lack of effect of cimetidine on action of phenprocoumon.

Authors:  J Harenberg; R Zimmermann; C Staiger; J X de Vries; E Walter; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

6.  Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver.

Authors:  K W Bock; G Brunner; H Hoensch; E Huber; D Josting
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 7.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

8.  The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.

Authors:  E E Ohnhaus; W Berger; F Duckert; F Oesch
Journal:  Klin Wochenschr       Date:  1983-09-01

9.  Cimetidine does not increase the anticoagulant effect of phenprocoumon.

Authors:  J Harenberg; C Staiger; J X de Vries; E Walter; E Weber; R Zimmermann
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.